934 related articles for article (PubMed ID: 22212951)
1. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
[TBL] [Abstract][Full Text] [Related]
2. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
Lencioni R; Chen XP; Dagher L; Venook AP
Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
[TBL] [Abstract][Full Text] [Related]
3. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
Choi JY
Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
[TBL] [Abstract][Full Text] [Related]
4. Management of HCC.
de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
[TBL] [Abstract][Full Text] [Related]
5. The intermediate hepatocellular carcinoma stage: Should treatment be expanded?
Piscaglia F; Bolondi L
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S258-63. PubMed ID: 20547312
[TBL] [Abstract][Full Text] [Related]
6. Current treatment strategy for hepatocellular carcinoma.
Ng KK; Poon RT
Saudi Med J; 2007 Sep; 28(9):1330-8. PubMed ID: 17768455
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
Kudo M
Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
[TBL] [Abstract][Full Text] [Related]
8. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.
Raoul JL; Sangro B; Forner A; Mazzaferro V; Piscaglia F; Bolondi L; Lencioni R
Cancer Treat Rev; 2011 May; 37(3):212-20. PubMed ID: 20724077
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
10. Management of hepatocellular carcinoma.
Yu AS; Keeffe EB
Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary management of nonresectable hepatocellular carcinoma.
Park HC; Seong J; Tanaka M; Zeng ZC; Lim HY; Guan S; Bae SH; Tak WY
Oncology; 2011; 81 Suppl 1():134-40. PubMed ID: 22212947
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatocellular carcinoma.
Forner A; Hessheimer AJ; Isabel Real M; Bruix J
Crit Rev Oncol Hematol; 2006 Nov; 60(2):89-98. PubMed ID: 16860993
[TBL] [Abstract][Full Text] [Related]
13. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
Llovet JM; Fuster J; Bruix J;
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S115-20. PubMed ID: 14762851
[TBL] [Abstract][Full Text] [Related]
14. Advanced HCC: emerging molecular therapies.
Finn RS
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):25-34. PubMed ID: 22419002
[TBL] [Abstract][Full Text] [Related]
15. Current strategy for staging and treatment: the BCLC update and future prospects.
Forner A; Reig ME; de Lope CR; Bruix J
Semin Liver Dis; 2010 Feb; 30(1):61-74. PubMed ID: 20175034
[TBL] [Abstract][Full Text] [Related]
16. Liver Cancer Working Group report.
Kudo M; Han KH; Kokudo N; Cheng AL; Choi BI; Furuse J; Izumi N; Park JW; Poon RT; Sakamoto M
Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i19-27. PubMed ID: 20870915
[TBL] [Abstract][Full Text] [Related]
17. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
Yamakado K; Kudo M
Oncology; 2014; 87 Suppl 1():78-81. PubMed ID: 25427737
[TBL] [Abstract][Full Text] [Related]
19. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.
Kudo M; Ueshima K
Oncology; 2010 Jul; 78 Suppl 1():154-66. PubMed ID: 20616599
[TBL] [Abstract][Full Text] [Related]
20. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
Jiang W; Zeng ZC
Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
